Ten new differently substituted 3-benzyl-5-aryl-3,5-dihydro-4-benzo[6,7]chromeno[2,3-]pyrimidin-4,6,11-triones were synthesized by a simple and cost-efficient procedure in a one-pot, three-component reaction from readily available ethyl 2-amino-4-aryl-5,10-dioxo-5,10-dihydro-4-benzo[]chromene-3-carboxylates, benzylamine and triethyl orthoformate under solvent- and catalyst-free conditions. All the new compounds were screened for their antiproliferative activity against two colorectal-cancer-cell lines. The results showed that the compounds 3-benzyl-5-phenyl-3,5-dihydro-4-benzo[6,7]chromeno[2,3-]pyrimidine-4,6,11-trione () and 3-benzyl-5-(3-hydroxyphenyl)-3,5-dihydro-4-benzo[6,7]chromeno[2,3-]pyrimidine-4,6,11-trione () exhibited the most potent balanced inhibitory activity against human LoVo and HCT-116 cancer cells.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694646 | PMC |
http://dx.doi.org/10.3390/molecules27227878 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!